Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)

PHASE3TerminatedINTERVENTIONAL
Enrollment

642

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

November 15, 2019

Study Completion Date

April 23, 2020

Conditions
Multiple Sclerosis
Interventions
DRUG

MD1003 100mg capsule

DRUG

PLACEBO

an inactive substance

Trial Locations (92)

2050

Brain and Mind Centre/University of Sydney, Sydney

2500

Valeomed Kft, Esztergom

2650

UZ Antwerpen, Edegem

3050

The Royal Melbourne Hospital, Parkville

3084

Austin Hospital, Heidelberg

3500

Jessa Ziekenhuis - Campus Virga Jesse, Hasselt

9000

UZ Gent, Halle

10029

Mount Sinai School of Medicine - Corinne Goldsmith Dickinson Center for MS, New York

10032

Columbia University Medical Center, New York

10117

Charité - Universitätsmedizin Berlin / NeuroCure Clinical Research Center, Berlin

11794

State University of New York (SUNY), Stony Brook

14203

UBMD Neurology, Buffalo

14642

University of Rochester Medical Center, Rochester

17190

Hospital Santa Caterina, Salt

19107

Thomas Jefferson University, Philadelphia

20132

Ospedale San Raffaele, IRCCS, Milan

21287

The Johns Hopkins Outpatient Center, Baltimore

22179

MultipEL Studies Institut für klinische Studien GbR, Hamburg

22903

University of Virginia Health System, Charlottesville

27607

Raleigh Neurology Associates, P.A., Raleigh

28040

Hospital Clínico San Carlos, Madrid

28223

Hostipal Universitario Quirónsalud Madrid, Pozuelo de Alarcón

29010

Hospital Regional Universitario de Málaga, Málaga

33136

University of Miami Miller School of Medicine, Miami

33612

University of South Florida - Neurology, Tampa

34209

Nova Clinical Research, LLC, Bradenton

37215

Vanderbilt Comprehensive Multiple Sclerosis Center, Nashville

37920

New Orleans Center for Clinical Research, Knoxville

40225

Heinrich-Heine-Universität Düsseldorf, Düsseldorf

41950

Servicio de Neurología Hospital Vithas Nisa Aljarafe, Castilleja de la Cuesta

44195

Cleveland Clinic Mellen Center for MS, Cleveland

48201

Wayne State University - Comp Clinic and MS Center, Detroit

55139

Ondokuz Mayis University Medical Faculty, Samsun

55422

Minneapolis Clinic of Neurology, LTD, Golden Valley

60611

Northwestern University - Feinberg School of Medicine, Chicago

60637

University of Chicago Medical Center-Duchossois Center for Advanced Medicine (DCAM), Chicago

63110

Washington University School of Medicine, St Louis

64711

Neuro Centrum Science GmbH, Erbach im Odenwald

66160

University of Kansas Medical Center, Kansas City

66214

Rowe Neurology Institute, Lenexa

70121

Ochsner Health System, New Orleans

75390

University of Texas Southwestern Medical Center, Dallas

78681

Central Texas Neurology Consultants, Round Rock

80045

University of Colorado Denver, Aurora

81377

Ludwig-Maximilians Universität München, München

85013

Barrow Neurology Clinics (BNC), Phoenix

85259

Mayo Clinic Scottsdale, Scottsdale

87131

The University of New Mexico - Multiple Sclerosis Specialty Clinic, Albuquerque

89073

Neuropoint GmbH, Ulm

89081

Poliklinik für Neurologie Universitätsklinikum Ulm, Ulm

90033

University of Southern California Keck School of Medicine, Los Angeles

92663

MS Center of California, Newport Beach

93710

Neuro-Pain Medical Center, Fresno

94158

UCSF Multiple Sclerosis Center, San Francisco

94705

Jordan Research And Education Institute Of Alta Bates Summit, Berkeley

95817

UC Davis Health System, Sacramento

97225

Providence Multiple Sclerosis Center, Portland

97980

Caritas Krankenhaus, Bad Mergentheim

98101

Virginia Mason Medical Center, Seattle

06473

Yale New Haven Hospital, North Haven

02115

Harvard Medical School - Brigham and Women's Hospital - Center for Neurologic Diseases, Boston

07666

Holy Name Hospital, Teaneck

V5G 2X6

Burnaby Hospital, Burnaby

V6T 2B5

Vancouver Hospital and Health Sciences Centre, Vancouver

E1C 2Z3

Hôpital universitaire Dr George L-Dumont university Hospital, Moncton

B3H 4K4

Nova Scotia Rehabilitation Center, Halifax

ON K1H 8L6

Ottawa Hospital General Campus, Ottawa

M5B 1W8

St. Michael's Hospital, Toronto

H2L 4M1

Hopital de Notre Dame, Montreal

H3A 2B4

Montreal Neurologic Institute, Montreal

500 03

doc. MUDr. Radomir Talab, CSc., neurologie, Hradec Králové

586 33

Nemocnice Jihlava, Jihlava

128 21

Vseobecna fakultni nemocnice v Praze, Prague

150 06

Fakultni nemocnice v Motole, Prague

415 29

Nemocnice Teplice, Teplice

04103

Universitätsklinikum Leipzig A.ö.R. - Klinik und Poliklinik, Leipzig

04779

Fachkrankenhaus Hubertusburg, Wermsdorf

00189

AO S.Andrea, Università degli Studi di Roma La Sapienza, Roma

85-794

Nasz Lekarz Ośrodek Badań Klinicznych, Bydgoszcz

80-803

COPERNICUS PL sp z o.o.,Szpital im. M.Kopernika Oddział Neurologiczny, Gdansk

67-100

Twoja Przychodnia Centrum Medyczne Nowa Sol, Nowa Sól

01-868

Centrum Medyczne Pratia Warszawa, Warsaw

08003

Hospital del Mar Servicio de Neurología, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

413 45

Sahlgrenska Universitetssjukhus - MS Center forskningsenheten, Gothenburg

171 76

Karolinska University Hospital - Neurologmottagningen, Stockholm

EH16 4SB

The University of Edinburgh, Edinburgh

G51 4TF

Institute of Neurological Sciences, Glasgow

E1 2AT

Barts And The London School Of Medicine And Dentistry Institute, London

WC1N 3BG

University College London Institute of Neurology / National Hospital for Neurology & Neurosurgery, London

NE1 4LP

Tyne Hospitals NHS Foundation, Newcastle upon Tyne

M6 8HD

Salford Royal Hospital, Salford

Sponsors
All Listed Sponsors
lead

MedDay Pharmaceuticals SA

INDUSTRY

NCT02936037 - Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) | Biotech Hunter | Biotech Hunter